{"slideshow_credits": null, "snippet": "Early results of clinical trials raised hopes that the therapies would be critical new additions to the treatment arsenal for those at risk of heart disease.", "abstract": "Advisory panel recommends that Food and Drug Admin approve evolocumab, second in new class of drugs that can drastically lower cholesterol levels; doctors hope drugs may help those at high risk of heart attack who are unable to control their conditions with statins.", "section_name": "Health", "print_page": "15", "document_type": "article", "byline": {"person": [{"firstname": "Gina", "role": "reported", "lastname": "KOLATA", "rank": 1, "organization": ""}], "original": "By GINA KOLATA"}, "web_url": "http://www.nytimes.com/2015/06/11/us/panel-tells-fda-to-back-second-drug-to-help-heart.html", "lead_paragraph": "Early results of clinical trials raised hopes that the therapies would be critical new additions to the treatment arsenal for those at risk of heart disease.", "headline": {"main": "Panel Tells F.D.A. to Back Second Drug to Help Heart ", "print_headline": "Panel Tells F.D.A. to Back Second Drug to Help Heart "}, "_id": "5578e2ce38f0d808b502d37f", "word_count": "890", "multimedia": [{"height": 126, "url": "images/2015/06/11/science/11DRUG/11DRUG-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/06/11/science/11DRUG/11DRUG-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2015/06/11/science/11DRUG/11DRUG-articleLarge.jpg", "legacy": {"xlarge": "images/2015/06/11/science/11DRUG/11DRUG-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/06/11/science/11DRUG/11DRUG-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/06/11/science/11DRUG/11DRUG-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-06-11T00:00:00Z", "source": "The New York Times", "news_desk": "National", "keywords": [{"name": "subject", "value": "Heart", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Cholesterol", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "3"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "Y", "rank": "4"}, {"name": "subject", "value": "Statins (Cholesterol-Lowering Drugs)", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}